psoriasis

(redirected from Psoriasis vulgaris)
Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.

pso·ri·a·sis

 (sə-rī′ə-sĭs)
n.
A noncontagious inflammatory skin disease characterized by recurring reddish patches covered with silvery scales.

[Greek psōriāsis, itch, mange, from psōriān, to have the itch, from psōrā, itch.]

pso′ri·at′ic (sôr′ē-ăt′ĭk) adj.

psoriasis

(səˈraɪəsɪs)
n
(Pathology) a skin disease characterized by the formation of reddish spots and patches covered with silvery scales: tends to run in families
[C17: via New Latin from Greek: itching disease, from psōra itch]
psoriatic adj

pso•ri•a•sis

(səˈraɪ ə sɪs)

n.
a common chronic, inflammatory skin disease characterized by scaly patches.
[1675–85; < New Latin < Greek psōríāsis=psōriā-, variant s. of psōriân to have an itch (derivative of psṓra itch) + -sis -sis]
pso•ri•at•ic (ˌsɔr iˈæt ɪk, ˌsoʊr-) adj.

psoriasis

A condition in which areas of skin thicken, redden, and often develop a silvery, scaled top layer. This develops because new cells are being produced at a faster rate than normal. The cause is unknown, but an attack can be triggered by stress or infection.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.psoriasis - a chronic skin disease characterized by dry red patches covered with scalespsoriasis - a chronic skin disease characterized by dry red patches covered with scales; occurs especially on the scalp and ears and genitalia and the skin over bony prominences
disease of the skin, skin disease, skin disorder - a disease affecting the skin
acanthosis - an abnormal but benign thickening of the prickle-cell layer of the skin (as in psoriasis)
Translations

psoriasis

[səˈraɪəsɪs] Nsoriasis f

psoriasis

nSchuppenflechte f, → Psoriasis f (spec)

psoriasis

[sɒˈraɪəsɪs] npsoriasi f

pso·ri·a·sis

n. psoriasis, dermatitis crónica que se manifiesta con manchas rojas cubiertas de escamas blancas;
___ annularis___ anular;
circular ______ pustular con pústulas;
___ universalis___ generalizada.

psoriasis

n psoriasis f
References in periodicals archive ?
Food and Drug Administration (FDA) has approved EnstilarA (calcipotriol/betamethasone dipropionate 50 micrograms/g / 0,5 mg/g) Foam for the treatment of psoriasis vulgaris in patients 18 years of age or older in the United States.
In this single-dose, randomized, double-blind, placebo-controlled study 63 subjects with mild-to-moderate psoriasis vulgaris (PASI <10) were randomly divided into two groups treated with topical steroids and orally with Meriva, or with topical steroids alone, both for 12 weeks.
calcipotriol/betamethasone dipropionate 50 micrograms/g / 0,5 mg/g), the Company's dual-action investigational aerosol foam for the treatment of psoriasis vulgaris, provided rapid itch relief and improvements in itch-related sleep loss for patients suffering from psoriasis.
Ayrica psoriasis vulgaris disinda inflamatuvar deri hastaligi olan, psoriatik artrit ve psoriasis vulgaris disinda psoriasisin diger formlarina sahip psoriasis hastalari, herhangi bir hastalik icin immunsuprese ilac tedavisi altinda olan hastalar calismaya dahil edilmedi.
Possible contribution of stem cell factor in psoriasis vulgaris.
Bullous pemphigoid may be associated with other autoimmune diseases such as diabetes, pernicious anemia, rheumatoid arthritis, multiple sclerosis and chronic inflammatory diseases such as lichen planus, psoriasis vulgaris as well as some malignancies and drug use.
Psoriasis vulgaris is a chronic, relapsing, immune-mediated, potentially devastating disease, influenced by genetic and environmental factors, that can cause substantial morbidity and psychological stress and have a profound negative impact on patient quality of life.
METHODS: Fifty-one patients with psoriasis vulgaris were randomly assigned to a treatment or a control group.
Fototerapiyi tercih etme acisindan psoriasis vulgaris, palmoplantar psoriasis ve vitiligo tanilari ile izlenmis olmak herhangi bir farklilik yaratmamistir (p=0.
1%) is one of the standard treatments for psoriasis in Thailand and reportedly it is effective for treatment of mild to moderate psoriasis vulgaris [25-27].
29) Finally, clinical efficacy and safety of FAE therapy have been proven in a large number of patients with severe psoriasis vulgaris in a prospective multicentre study.
Tokyo, Japan, June 26, 2006 - (JCN) - Teijin Pharma and Sato Pharmaceutical jointly announced on June 26 that they will begin marketing Bonalfa High Lotion 20 mu-g/g (tacalcitol), an ethical agent for treating psoriasis vulgaris, on June 27.